Please Wait
Applying Filters...
menu
    • menu
    DMF filings hit all-time high in Q3 2024; China tops list with 58% increase in Type II submissions

    Data Compilation
    #PharmaFlow

    Pipeline Prospector Sept 2024: BMS wins landmark FDA approval for schizophrenia med; Sanofi’s Dupixent okayed for COPD

    Stock Recap
    #PipelineProspector

    Menu

    Sulfadimidine

    ACTIVE PHARMA INGREDIENTS

    FINISHED DOSAGE FORMULATIONS

    RELATED EXCIPIENT COMPANIES

    EXCIPIENTS BY APPLICATIONS

    MARKET PLACE

    REF. STANDARDS & IMPURITIES

    ANALYTICAL

    PharmaCompass
    $ API Ref.Price (USD/KG) : 12Xls download

    Filters

    clear-filterReset all filters
    ListList of Suppliers
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    Data in the table can be downloaded after upgrading. In the meantime, you can access the data through the menu.

    Last Updated on PharmaCompass Virtual Booth Country Certificate Holder Certificate No. Substance Issue Date Status Type End Date Substance No.
    28/10/2024 Nanhai Beisha Pharmaceutical
    China
    		 NANHAI BEISHA PHARMACEUTICAL CO., LTD. Foshan City CN R1-CEP 2001-261 - Rev 01 Sulfadimidine 2020-07-28 Valid Chemical 295
    28/10/2024 Southwest Synthetic Pharmaceutical
    China
    		 SOUTHWEST SYNTHETIC PHARMACEUTICAL CORPORATION, LIMITED Chongqing CN R1-CEP 1995-039 - Rev 06 Sulfadimidine 2015-12-08 Withdrawn by EDQM Failure to CEP procedure Chemical 2021-05-21 295